Benjamin Jewett, MD
Neurology · Charleston, SCNPI 1184283889
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,239 of the $6,863 with a category attached, or 76.3%. 31 manufacturers reported payments, led by Lilly USA, LLC at 26.1% of the total.
Across 274 payments — averaging $25.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$2K
- UCB, Inc.$1K
- AbbVie$618
- Pfizer$387
- Neurelis, Inc.$342
- Jazz Pharmaceuticals Inc.$337
- plus $2K from 25 others
What the payments were for
- Consulting fees$1,60023%
- Speaking & faculty fees$240%
- Food & beverage$5,23976%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 13 | $1,790 |
| UCB, Inc. | 39 | $1,045 |
| AbbVie | 53 | $618 |
| Pfizer | 38 | $387 |
| Neurelis, Inc. | 10 | $342 |
| Jazz Pharmaceuticals Inc. | 11 | $337 |
| TG Therapeutics, Inc. | 7 | $277 |
| Lundbeck LLC | 15 | $251 |
| Argenx US, Inc. | 13 | $225 |
| MDD US Operations, LLC | 11 | $196 |
| Eisai Inc. | 9 | $175 |
| AstraZeneca(2 entities) | 5 | $125 |
| Neurocrine Biosciences, Inc. | 6 | $125 |
| Grifols USA, LLC | 5 | $114 |
| Novartis | 5 | $108 |
| EMD Serono, Inc. | 6 | $107 |
| Livanova USA, Inc. | 1 | $82 |
| Vanda Pharmaceuticals Inc. | 3 | $74 |
| Bristol Myers Squibb | 4 | $69 |
| CSL Behring | 3 | $63 |
| Scilex Pharmaceuticals Inc. | 3 | $60 |
| Ipsen Biopharmaceuticals, Inc | 2 | $40 |
| Catalyst Pharmaceuticals, Inc. | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Medtronic | 1 | $28 |
| GE HealthCare | 1 | $28 |
| Amneal Pharmaceuticals LLC | 2 | $28 |
| Sanofi | 1 | $26 |
| Genentech USA, Inc. | 1 | $24 |
| Sanara Medtech Inc. | 1 | $24 |
| Merz Pharmaceuticals, LLC | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KISUNLA$1,600
How this compares
$6,863 in reported general payments places this provider in the 75th percentile of 270 neurology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AptiomEslicarbazepine Acetate | 12 | $26,067 |
| XcopriCenobamate | 18 | $21,301 |
| Emgality PenGalcanezumab-Gnlm | 12 | $14,375 |
| MyrbetriqMirabegron | 19 | $8,984 |
| Lacosamide | 51 | $5,934 |
| Levetiracetam | 76 | $3,229 |
| Acetazolamide | 13 | $2,637 |
| Carbamazepine ErCarbamazepine | 15 | $2,115 |
| Lamotrigine | 61 | $1,087 |
| Clobazam | 15 | $1,079 |
| Oxcarbazepine | 14 | $755 |
| Zonisamide | 20 | $463 |
| Divalproex Sodium ErDivalproex Sodium | 17 | $431 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 24 | $304 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 20 | $241 |
Paid to pharmacies, not to this prescriber.
Other neurology in Charleston
- Robert AdamsCharleston$204K
- Sarah BreevoortCharleston$90K
- Tanya TuranCharleston$77K
- Katherine RuzhanskyCharleston$52K
- Jonathan HalfordCharleston$48K
- Andrew KeeganCharleston$48K
- Aljoeson WalkerCharleston$35K
- Hamid BahadoriCharleston$29K
- Bruce OvbiageleCharleston$27K
- Andrew AmeriCharleston$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.